Federal grants to Haima Therapeutics LLC
Haima Therapeutics LLC in Cleveland, Ohio received $3.4 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Cardiovascular Diseases Research, with $3.1 million. In fiscal 2025 it was awarded $994,676.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$3.4 million
- Awards4
- Awarded in FY 2025$994,676
- Largest award$2.1 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $199,861 |
| FY 2022 | 0 | $0 |
| FY 2023 | 2 | $1.1 million |
| FY 2024 | 1 | $1.1 million |
| FY 2025 | 2 | $994,676 |
Programs that fund Haima Therapeutics LLC
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 2 | $3.1 million |
| Engineering | 1 | $199,861 |
| Military Medical Research and Development | 1 | $99,950 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 2 | $3.1 million |
| National Science Foundation | 1 | $199,861 |
| Department of Defense | 1 | $99,950 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Synthoplate: intravenous hemostatic nanotechnology to mitigate bleeding in thrombocytopenia - project summary/abstract the normal platelet count in human blood is 150,000-400,000/Μl, and these platelets are responsible for efficient hemostatic surveillance and bleeding mitigation in the body. Thromb | Cardiovascular Diseases Research | June 1, 2023 | $2.1 million |
| A novel platelet-inspired nanotechnology to restore hemostasis in patients on antiplatelet agents - project summary/abstract antiplatelet therapy with P2Y12 inhibitors (clopidogrel, ticagrelor etc.) is widely used to prevent thrombotic events in patients with cardiovascular disease. However, these a | Cardiovascular Diseases Research | July 11, 2025 | $944,676 |
| Sbir phase II: manufacturing and characterization of a synthetic platelet (synthoplatetm) technology | Engineering | February 18, 2021 | $199,861 |
| Synthoplate-enriched plasma for enhanced hemostatic resuscitation in trauma | Military Medical Research and Development | December 23, 2020 | $99,950 |
Questions people ask
How much federal grant money does Haima Therapeutics LLC get?
$3.4 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Haima Therapeutics LLC the most?
The Department of Health and Human Services, with $3.1 million in 2 awards. The National Science Foundation and the Department of Defense follow.
What is Haima Therapeutics LLC's largest federal grant?
$2.1 million under Cardiovascular Diseases Research, with its first action in the period on June 1, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Haima Therapeutics LLC?
Its largest are Cardiovascular Diseases Research, Engineering and Military Medical Research and Development.
Other grant recipients in Cleveland
- Case Western Reserve University
- Greater Cleveland Regional Transit Authority
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
- Cuyahoga Metropolitan Housing Authority
- City of Cleveland
- Growth Opportunity Partners, Inc
- Emerald Development & Economic Network Inc
- Cuyahoga County
Largest federal grant recipients in Ohio · Federal grants in Ohio